Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs WIR ASIA Tbk. (WIRG)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan WIR ASIA Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan WIR ASIA Tbk. diperdagangkan di Rp77 (kapitalisasi pasar 955,09 M, volume 24 jam 774,95 jt). Perbedaan utamanya: WIR ASIA Tbk. jauh lebih besar — sekitar 9,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WIRG | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 955,09 M |
Volume | — | 774,95 jt |
Lot | — | 7,75 jt |
Perputaran | — | 61,67 M |
Harga Rata-rata | — | 79,57 |
Nilai Transaksi | — | 61,67 M |
Harga Ekuilibrium Indikatif | — | 77 |
Volume Ekuilibrium Indikatif | — | 33,81 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang WIR ASIA Tbk.
PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Selengkapnya di halaman WIRG →
